07-07-2021 дата публикации
Номер: GB0002590692A
Принадлежит:
A composition comprising i.) a parathyroid hormone, or derivative, from 0.1 ng/mL to 50 ng/mL, ii.) a bisphosphonate, or derivative, strontium ranelate, denosumab, or romosozumab, or a combination, from 1 ng/mL to 6000 ng/mL, and iii.) a delivery material for the composition in a solid or liquid phase, which may be selected form calcium sulphate (sulfate), (mono, di or tri) calcium phosphates, calcium carbonates, autograft bone material, (synthetic) allograft, ceramic, calcium sodium phosphosilicate, collagen sponge, carboxymethylcellulose (CMC), polymethyl methacrylate (PMMA), bone cement, or a combination. The bisphosphonate may be selected from zoledronic acid, alendronic acid, etidronate, pamidronate, ibandronic acid, risedronate, clodronate, or a combination. The parathyroid may be parathyroid-related protein (PTHrP), 1-34 or 1-84 recombinant human parathyroid hormone (1-34 rhPTH or 1-84 rhPTH) H05AA03 parathyroid hormone, preotact parathyroid hormone, teriparatide, abaloparatide, ...
Подробнее